A major new study in Communications Medicine offers a quietly troubling conclusion. Humanity is living longer, yet a growing portion of that extended life is spent in poor health. The distance between how long we live and how long we live well is widening across every region of the world. Behind the demographic curve sits a political question: what if the same forces that prolong life, namely technology and industrialization, are also increasing the percentage of our lives spent unwell?
This finding resonates with a long tradition of critical thought on industrial modernity. Herbert Marcuse argued that advanced industrial society narrows the horizon of freedom by absorbing critique into a “one-dimensional” order. Similarly, Marshall Berman described modernity as a world in which individuals are swept into transformations so rapid that “all that is solid melts into air,” generating exhilaration and disorientation in equal measure. These thinkers understood industrialization as a process that expands technical power while eroding the texture of everyday life.
Notwithstanding, the argument here follows a related but more literal thread. Rather than stressing cultural alienation, it takes Armin Garmany and Andre Terzic’s healthspan-lifespan analysis as evidence that industrialization may be reshaping the biological and temporal structure of human lives. In epidemiological terms, a growing share of the life course is now lived in states of morbidity produced or intensified by the very socio-technical systems that keep us alive: the more technologically saturated life becomes, the more its later decades appear to be lived in compromised health.
Drawing on World Health Organization data from 183 countries, Garmany and Terzic show that the median global gap between life expectancy and healthy life expectancy is nine years. In the United States, it exceeds 12. Although Gross Domestic Product (GDP) is not a definitive indicator of high-functioning or equitable health systems, it captures broad patterns of economic development that usually align with more technologically intensive medical infrastructures. Using GDP in this limited sense as a rough marker of the scale and saturation of health technologies reveals a striking paradox: the wealthiest and most industrialized states, often possessing the most advanced medical capacities, also record some of the longest periods of life lived in poor health.
At the same time, the fastest expansion of the gap is occurring in rapidly industrializing regions, especially in Africa. Although Africa still records shorter lifespans and slightly smaller gaps in absolute terms, it exhibits the most rapid restructuring of disease patterns. The problem first created by industrialized countries is now emerging in regions racing through their own industrial transitions.
The standard development narrative attributes rising lifespans to industrialization’s achievements: safer water, effective drugs, sophisticated medical procedures and higher material living standards. These gains are undeniable, but they coexist with a profound epidemiological shift. As infectious diseases recede, noncommunicable conditions (cardiovascular disease, cancer, metabolic and musculoskeletal disorders and neurological decline) now define the global burden of illness.
Garmany and Terzic’s data reveal how this shift interacts with economic development. Countries with higher GDPs tend to experience both longer lives and longer periods of morbidity, suggesting that technological capacity itself may sustain forms of frailty that would not otherwise persist. This pattern is no longer confined to the Global North. Rapidly industrializing regions, particularly in Africa, are undergoing the same transition toward chronic disease while still contending with infectious and nutritional challenges. The overlap produces a dual burden that strains health systems far earlier in the development trajectory than it did in wealthier states.
Although the study correlates the widening healthspan–lifespan gap to the global diffusion of technological and industrial development, its data cannot yet determine why the correlation persists. The pattern leaves open several possibilities:
Either (1) industrialization is reshaping the biological tempo of aging itself. In effect, medical advances appear structurally more capable of extending life than of enhancing the quality of the added years. The result is an unintended expansion of the period spent in morbidity.
Or (2) the deeper issue may be political. When industrial systems are organized around profit maximization rather than public health, societies generate environments that intensify chronic illness: pollution is externalized, food systems privilege durability over nutrition, cities are designed around automobiles rather than rest and movement, workplaces are digitally intensified and health systems intervene episodically rather than transforming the upstream conditions that produce disease.
Regardless, what the evidence does confirm is a shared outcome. As societies become more industrialized and technologically saturated, people spend more of their lives managing chronic conditions or disability. Regions such as Africa, industrializing rapidly and often without strong social protections, risk inheriting not only new technologies but also the widening burdens that accompany them.
This structural paradox complicates the very meaning of progress in industrial societies. Does technological advancement represent progress if it consistently enlarges the share of life spent unwell? Narrowing the gap must therefore be a central policy goal, since extending life, or even extending healthy years in isolation, is ultimately insufficient.
The consequences of these findings grow more acute when placed within contemporary demographic transitions. Across much of the industrialized world, birthrates have fallen below replacement levels.
Stagnant wages, unaffordable housing, precarity, and rising childrearing costs discourage family formation. At the same time, the global resurgence of misogynistic political culture places new constraints on reproductive autonomy. Welfare states, however, were built on the assumption of a large working-age population supporting a smaller retired cohort. As populations age and working-age cohorts contract, this fiscal model becomes unsustainable. Longer lives cannot stabilize the system if those additional years are lived in poor health.
The situation worsens as immigration becomes more politically contested. For decades, wealthy states compensated for low birthrates by importing labour from the Global South, often through programs marked by racialized inequalities. Canada’s Temporary Foreign Worker Program, for example, has been described by the United Nations as a modern form of indentured servitude. Yet, just as these systems face long-overdue scrutiny, political movements across Europe and North America have hardened against immigration altogether. The result is a widening contradiction: economic systems rely on sustained labour inflows that political systems are now unwilling to authorize.
Population decline and the growing burden of chronic illness therefore reinforce one another. Fewer workers must support larger medically dependent populations, while workers themselves experience early-onset chronic conditions. Institutions designed for an earlier demographic era now confront the simultaneous pressures of expanding morbidity and diminishing population renewal.
What emerges is a paradox that existing frameworks of economic and social organization seem unable to assimilate. Societies are achieving unprecedented longevity, but the very conditions that produce these gains generate vulnerabilities that longer lives cannot offset. In this context, improvements in absolute longevity matter little if the relative gap continues to widen and if the populations living those additional years are less able to sustain the labour and fiscal foundations on which current systems depend. The study’s findings therefore pose a more fundamental question: if this is the form progress takes under contemporary industrialization, how stable can it be?
Further, whether this trajectory reflects something inherent in the way medicinal advancements and technology function or instead stems from the policies that govern their uneven and profit-oriented implementation remains unresolved. What the evidence does show is that longer life is increasingly decoupled from longer well-being, and the consequences of that divergence are only beginning to come into view.
